In March 2025, the company announced new strategies for just a immediate-to-consumer giving of its Wegovy weight loss drug. The company recognized a new pharmacy, termed NovoCare, which might cost prospects $499 a month for access to the drug, less than fifty percent the cost of the drug by mean